
An easy-to-administer urine test looking for telomerase reverse transcriptase mutations helps detect recurring urothelial bladder cancer, especially non-muscle-invasive bladder cancer, early on, according to a new study.
Lisette Hilton is a writer in Boca Raton, Fla., who heads up her company, Words Come Alive.

Published: July 21st 2017 | Updated: